Search research articles
Contact Us
Filters
Showing results (1-10 of 60) with videos related to
Page
of 6
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
September 2, 2021
In Reply to Halperin
Deborah C Marshall
JAMA Oncology
|
October 3, 2024
Moving the Needle on Equity in Prostate Cancer
Deborah C Marshall
Gynecologic Oncology
|
December 26, 2023
Associations between pharmaceutical industry payments to physicians and prescription of PARP inhibitors in the United States
Anju Murayama, Deborah C Marshall
Nature Reviews. Urology
|
April 28, 2022
Top, bottom or vers? Creating a more equitable health system for sexual and gender minority patients with prostate cancer
Daniel R Dickstein, Deborah C Marshall
JAMA Oncology
|
May 27, 2021
Industry Payments to Medical Oncologists-Reply
Deborah C Marshall, Elizabeth S Tarras, Susan Chimonas
Nature Reviews. Urology
|
May 8, 2024
We all get erections - de-gendering sexual arousal dysfunction in the ICD
Lucy Greenwald, Daniel R Dickstein, Barbara Chubak, et al.
Mayo Clinic Proceedings
|
January 15, 2016
Disclosure of Industry Payments to Physicians: An Epidemiologic Analysis of Early Data From the Open Payments Program
Deborah C Marshall, Madeleine E Jackson, Jona A Hattangadi-Gluth
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 23, 2024
Pharmaceutical industry payments and prescriptions of direct acting antiviral drugs for hepatitis C virus infection
Anju Murayama, Keith M Sigel, Elizabeth S Tarras, et al.
JAMA Oncology
|
December 30, 2020
Trends in Industry Payments to Medical Oncologists in the United States Since the Inception of the Open Payments Program, 2014 to 2019
Elizabeth S Tarras, Deborah C Marshall, Kenneth Rosenzweig, et al.
JAMA
|
November 3, 2020
Trends in Industry Payments to Physicians in the United States From 2014 to 2018
Deborah C Marshall, Elizabeth S Tarras, Kenneth Rosenzweig, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 60) with videos related to
Sort By:
Page
of 6
International Journal of Radiation Oncology, Biology, Physics
|
September 2, 2021
In Reply to Halperin
Deborah C Marshall
JAMA Oncology
|
October 3, 2024
Moving the Needle on Equity in Prostate Cancer
Deborah C Marshall
Gynecologic Oncology
|
December 26, 2023
Associations between pharmaceutical industry payments to physicians and prescription of PARP inhibitors in the United States
Anju Murayama, Deborah C Marshall
Nature Reviews. Urology
|
April 28, 2022
Top, bottom or vers? Creating a more equitable health system for sexual and gender minority patients with prostate cancer
Daniel R Dickstein, Deborah C Marshall
JAMA Oncology
|
May 27, 2021
Industry Payments to Medical Oncologists-Reply
Deborah C Marshall, Elizabeth S Tarras, Susan Chimonas
Nature Reviews. Urology
|
May 8, 2024
We all get erections - de-gendering sexual arousal dysfunction in the ICD
Lucy Greenwald, Daniel R Dickstein, Barbara Chubak, et al.
Mayo Clinic Proceedings
|
January 15, 2016
Disclosure of Industry Payments to Physicians: An Epidemiologic Analysis of Early Data From the Open Payments Program
Deborah C Marshall, Madeleine E Jackson, Jona A Hattangadi-Gluth
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 23, 2024
Pharmaceutical industry payments and prescriptions of direct acting antiviral drugs for hepatitis C virus infection
Anju Murayama, Keith M Sigel, Elizabeth S Tarras, et al.
JAMA Oncology
|
December 30, 2020
Trends in Industry Payments to Medical Oncologists in the United States Since the Inception of the Open Payments Program, 2014 to 2019
Elizabeth S Tarras, Deborah C Marshall, Kenneth Rosenzweig, et al.
JAMA
|
November 3, 2020
Trends in Industry Payments to Physicians in the United States From 2014 to 2018
Deborah C Marshall, Elizabeth S Tarras, Kenneth Rosenzweig, et al.
Page
of 6